Article info

Download PDFPDF

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson’s disease: a double blind, placebo controlled, randomised, multicentre study
Free
  1. Dr Michaela M Pinter, Ludwig Boltzmann Institute of Restorative Neurology, Neurological Hospital Maria Theresien Schloessel, Hofzeile 18–20, A-1190 Vienna, Austria. Telephone 0043 1 3683455; fax 0043 1 3683455 18; email 101606.3024{at}compuserve.com
View Full Text

Citation

Pinter MM, Pogarell O, Oertel WH
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson’s disease: a double blind, placebo controlled, randomised, multicentre study

Publication history

  • Received October 16, 1997
  • Revised July 17, 1998
  • Accepted September 11, 1998
  • First published April 1, 1999.
Online issue publication 
April 01, 1999

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.